Page last updated: 2024-11-02

pd 153035 and Pancreatic Neoplasms

pd 153035 has been researched along with Pancreatic Neoplasms in 2 studies

4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research Excerpts

ExcerptRelevanceReference
"MPC-83 pancreatic cancer cells were pre-treated and treated with EGF at different time points and then analyzed using western blotting."1.38Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3. ( Gong, K; Li, X; Liu, W; Luo, K; Wang, K, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camaj, P1
Seeliger, H1
Ischenko, I1
Krebs, S1
Blum, H1
De Toni, EN1
Faktorova, D1
Jauch, KW1
Bruns, CJ1
Liu, W1
Wang, K1
Gong, K1
Li, X1
Luo, K1

Other Studies

2 other studies available for pd 153035 and Pancreatic Neoplasms

ArticleYear
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells.
    Biological chemistry, 2009, Volume: 390, Issue:12

    Topics: Amino Acid Sequence; Cell Line, Tumor; ErbB Receptors; Extracellular Matrix Proteins; Humans; MAP Ki

2009
Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3.
    Molecular medicine reports, 2012, Volume: 6, Issue:3

    Topics: Antineoplastic Agents; Aquaporin 3; Butadienes; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors;

2012